WooGeneB&GCO.,Ltd
Founded in 1985 and listed on KOSDAQ in 2008, WooGene B&G is an animal pharmaceutical company that also operates pet food and treat businesses through subsidiaries OSP and Bowwow Korea.
As of 2026-10-11, WooGeneB&GCO.,Ltd has 24 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- Super Theaveterinary medicine
- Antipen SMveterinary medicine
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Shedding Kinetics and Infection Stage-Dependent Horizontal Transmission of Infectious Spleen and Kidney Necrosis Virus (ISKNV) in Angelfish (Pterophyllum scalare).
Animals : an open access journal from MDPI · 2026-09 · Choi SW, Jeong YJ, Baek EJ 외 3
- The Vaccine-Field Strain Gap in Bovine Neonatal Diarrhea: Molecular Epidemiology of Rotavirus, Coronavirus, and Enterotoxigenic Escherichia coli and Priorities for Vaccine Updating.
Vaccines · 2026-08 · Park GS, Park M, Lee S 외 2
- Integrated Field Evaluation of a Caseous Lymphadenitis Vaccine and Environmental Bacteriological Profiling in Commercial Goat Farms in South Korea.
Vaccines · 2026-08 · Park GS, Lee S, Park M 외 7
- Carbohydrate source modulates protein and amino acid digestibility patterns in domestic cats.
Frontiers in veterinary science · 2026-01 · Lee WJ, Oh ER, Seo JH 외 3
- Evaluation of dietary Bacillus-based commercial probiotics in broiler chickens.
Journal of animal science · 2026-01 · Vu VA, Kim SK, Bui HD 외 8
- Immunogenicity and vaccine efficacy of Actinobacillus pleuropneumoniae-derived extracellular vesicles as a novel vaccine candidate.
Virulence · 2025-12 · Hyun Park S, Kim YH, Lee HJ 외 6
- Phenotypic and genotypic profiling of swine-derived Shiga toxin-producing Escherichia coli over a decade in South Korea: a framework for edema disease vaccine candidate strains selection.
Frontiers in microbiology · 2025-01 · Park GS, Kim HJ, Cho MA 외 11
- Immunopathological features of highly pathogenic Korean Lineage B PRRSV-2: insights into virulence indicators and host immune responses.
Frontiers in immunology · 2025-01 · Park GS, Kim SC, Kim HJ 외 8
- A field evaluation of a new porcine circovirus type 2d and Mycoplasma hyopneumoniae bivalent vaccine in herds suffering from subclinical PCV2d infection and enzootic pneumonia.
Veterinary medicine and science · 2024-09 · Ham S, Suh J, Kim C 외 3
- First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models.
Pathogens (Basel, Switzerland) · 2024-08 · Park GS, Lee S, Jeong MA 외 12
Show 14 more publications
- Field efficacy of a novel porcine reproductive and respiratory syndrome modified-live virus vaccine with an emphasis on growth performance.
Veterinary medicine and science · 2024-07 · Ham S, Lee H, Suh J 외 4
- Evaluation of Formalin-Inactivated Vaccine Efficacy against Red Seabream Iridovirus (RSIV) in Laboratory and Field Conditions.
Vaccines · 2024-06 · Min JG, Kim GH, Kim CH 외 3
- Anti-inflammatory potential via the MAPK signaling pathway of Lactobacillus spp. isolated from canine feces.
PloS one · 2024-01 · Park MA, Park M, Jang HJ 외 5
- Pelargonium sidoides extract mediates nephrotoxicity through mitochondrial malfunction and cytoskeleton destabilization.
Toxicological research · 2023-10 · Lee JY, Lee J, Lee SH 외 2
- Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and Mycoplasma hyopneumoniae against a dual PCV2d and Mycoplasma hyopneumoniae challenge.
Frontiers in veterinary science · 2023-01 · Ham S, Suh J, Oh T 외 3
- Molecular characterization and antimicrobial susceptibility of Corynebacterium pseudotuberculosis isolated from skin abscesses of native Korean goats (Capra hircus coreanae).
Journal of applied microbiology · 2022-09 · Pathirana HNKS, Cho HS, Cho YI 외 9
- Complete genome sequencing and comparative genomic analysis of Lactobacillus acidophilus C5 as a potential canine probiotics.
Journal of animal science and technology · 2021-11 · Son S, Lee R, Park SM 외 4
- Single oral immunization of an attenuated Salmonella Gallinarium formulation consisting of equal quantities of strains secreting H9N2 hemagglutinin-HA1, HA2, and M2eCD154 induces significant protection against H9N2 and partial protection against Salmonella Gallinarium challenge in chickens.
Veterinary immunology and immunopathology · 2021-10 · Senevirathne A, Hewawaduge C, Park S 외 5
- Comparative genomics of canine Lactobacillus reuteri reveals adaptation to a shared environment with humans.
Genes & genomics · 2020-09 · Son S, Oh JD, Lee SH 외 2
- Selection and Characterization of Staphylococcus hominis subsp. hominis WiKim0113 Isolated from Kimchi as a Starter Culture for the Production of Natural Pre-converted Nitrite.
Food science of animal resources · 2020-07 · Hwang H, Lee HJ, Lee MA 외 6
- Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
Journal of microbiology and biotechnology · 2019-05 · Chun J, Cho Y, Park KH 외 7
- Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Journal of microbiology and biotechnology · 2019-03 · Jung BK, Kim HR, Lee YH 외 2
- Porcine epidemic diarrhea vaccine evaluation using a newly isolated strain from Korea.
Veterinary microbiology · 2018-07 · Park JE, Kang KJ, Ryu JH 외 5
- Algibacter agarivorans sp. nov. and Algibacter agarilyticus sp. nov., isolated from seawater, reclassification of Marinivirga aestuarii as Algibacter aestuarii comb. nov. and emended description of the genus Algibacter.
International journal of systematic and evolutionary microbiology · 2013-09 · Park SC, Hwang YM, Lee JH 외 2
Patents
KIPRIS · applicant-matched- 돼지 흉막폐렴구균(Actinobacillus pleuropneumoniae)으로부터 분리된 엑소좀을 포함하는 면역증진 개선용 조성물 및 돼지 흉막폐렴 예방 또는 치료용 백신 조성물
Published · 2024-12 · Application 1020240181855
Registered · 2024-11 · Application 1020240161912
Registered · 2023-12 · Application 1020230194998
Registered · 2023-12 · Application 1020230185801
Registered · 2023-05 · Application 1020230059715
Registered · 2022-05 · Application 1020220057266
Registered · 2021-05 · Application 1020210061250
Registered · 2020-10 · Application 1020200137229
Registered · 2020-01 · Application 1020200012137
Registered · 2020-01 · Application 1020200012138
Show 36 more patents
Rejected · 2020-01 · Application 1020200007605
Registered · 2019-02 · Application 1020190020995
Registered · 2018-11 · Application 1020180151127
Registered · 2018-11 · Application 1020180139719
Registered · 2018-05 · Application 1020180055554
Registered · 2018-01 · Application 1020180009820
Registered · 2018-01 · Application 1020180002188
Registered · 2017-10 · Application 1020170140133
Registered · 2016-09 · Application 1020160118002
Registered · 2016-08 · Application 1020160109432
Registered · 2015-12 · Application 1020150176133
Registered · 2015-10 · Application 1020150149815
Withdrawn · 2015-02 · Application 1020150021378
Rejected · 2014-10 · Application 1020140134047
Registered · 2014-02 · Application 1020140020881
Registered · 2014-02 · Application 1020140015822
Rejected · 2013-02 · Application 1020130016340
Rejected · 2011-09 · Application 1020110092003
Registered · 2008-12 · Application 1020080121638
Registered · 2008-12 · Application 1020080121637
Registered · 2007-12 · Application 1020070124781
Registered · 2007-12 · Application 1020070124780
Expired · 2005-12 · Application 1020050127746
Rejected · 2004-02 · Application 1020040013821
Expired · 2004-01 · Application 1020040001590
Expired · 2001-02 · Application 1020010006288
Rejected · 1998-05 · Application 1019980018810
Expired · 1997-12 · Application 1019970078403
Expired · 1997-12 · Application 1019970069265
Rejected · 1996-11 · Application 2019960041665
Expired · 1996-11 · Application 1019960056932
Expired · 1996-11 · Application 1019960056934
Expired · 1996-11 · Application 1019960056933
Expired · 1995-04 · Application 1019950008592
Expired · 1994-05 · Application 1019940010335
Expired · 1994-05 · Application 1019940010334
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot29
- GoogleGoogleOther2
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for WooGeneB&GCO.,Ltd and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition